EUVIMEDEUVIMED entdecken
Editorial

Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls

Helen MacKay iD, Italo Fernandes iD

Cancer · 2024

DOI: 10.1002/cncr.35448 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer, 2024. Verfasst von Helen MacKay und 1 weiteren Autor:innen. Beteiligte Einrichtung: Odette Cancer Centre, Sunnybrook Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blanc‐Durand and colleagues present a prospective analysis of cell‐free DNA in patients with recurrent, advanced, or metastatic endometrial cancer, which offers insights into its potential application in molecular classification and the evolving targeted therapy landscape of this disease. More research is needed to validate cell‐free DNA's clinical utility but its potential to guide therapy and improve patient outcomes warrants ongoing exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsNeoplasm Recurrence, LocalHumansFemaleNeoplasm MetastasisCell-Free Nucleic AcidsBiomarkers, TumorCirculating Tumor DNA

Substanzen

Cell-Free Nucleic AcidsBiomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • Odette Cancer Centre, Sunnybrook Research Institute, Toronto, Ontario, Canada.

ORCID-Profile: Helen MacKay, Italo Fernandes

Zitieren

APA

MacKay, H., & Fernandes, I. (2024). Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls. Cancer. https://doi.org/10.1002/cncr.35448

Vancouver

MacKay H, Fernandes I. Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls. Cancer. 2024. doi:10.1002/cncr.35448

BibTeX
@article{MacKay2024,
  author = {MacKay, Helen and Fernandes, Italo},
  title = {Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35448}
}
Kostenlos starten →